The North America omega 3 market was valued at USD 826.27 million in 2023, the base year. The market is anticipated to grow from USD 875.65 million in 2024 to USD 1,567.13 million by 2032, exhibiting a CAGR of 7.5% during the forecast period 2024–2032. Growth is fueled by heightened consumer awareness of the health benefits of omega-3 fatty acids and their integration into food and dietary supplements, while the United States dominated in 2023 with more than 38% of the market share.
Chronic Disease Burden and Consumer Awareness
A key driver of the North America omega 3 market is the escalating prevalence of chronic diseases such as cardiovascular disorders, arthritis, and cognitive impairments. The Centers for Disease Control and Prevention reported that approximately 695,000 people died of heart disease in 2021. Research on EPA and DHA underscores their potential to mitigate such risks and promote heart and brain health, so consumers are increasingly adopting omega-3-fortified products, including foods and supplements, as part of their daily dietary regimen.
Rising Healthcare Expenditure Spurs Demand
Escalating healthcare expenditure is a significant market driver. According to the Centers for Medicare & Medicaid Services, the U.S. National Health Expenditure rose 4.1% to USD 4.5 trillion in 2022. As healthcare expenditure consumes a larger portion of household budgets, individuals pursue preventive measures, and nutritional supplements and foods enriched with omega-3 fatty acids offer a convenient, accessible way to manage health proactively. Consumers view these products as part of a preventive regimen targeting cardiovascular support, cognitive function, and inflammation reduction.
Browse Insights:
https://www.polarismarketresearch.com/industry-analysis/north-america-omega-3-market
Marine Sources Hold the Largest Share
By source, marine-based omega-3 held the largest share in 2023. North America is rich in marine resources, including fish species high in EPA and DHA, and manufacturers benefit from industry maturity, efficient production processes, and established supply chains. Fish oil contains higher concentrations of these biologically active forms than plant-based sources such as flaxseed oil or algal oil, and marine-based omega-3 products are widely available as soft gel capsules, liquid oils, and fortified foods. By application, the pharmaceutical segment is projected to grow at the highest CAGR.
United States Leadership and Market Restraints
The United States accounted for the largest share in 2023, supported by a large population with high disposable income, a strong focus on health and wellness, and a well-developed healthcare infrastructure in which physicians, nutritionists, and pharmacists often recommend omega-3 supplements. A key restraint is the availability of alternative sources. Concerns about sustainability, environmental impact, and contaminants such as heavy metals may deter some consumers from fish oil products, and fish-derived supplements may not suit vegetarian or vegan diets, which could shift preferences toward algal options.
Competitive Intensity and Report Scope
The report's Porter's Five Forces assessment rates the bargaining power of suppliers and buyers as moderate, the threat of substitutes as moderate, the threat of new entrants as low, and rivalry among existing firms as high. Revenue is reported in USD million, with historical data for 2019–2022 and a country scope covering the United States and Canada. The market is also segmented by type into DHA, ALA, and EPA, and by source into plant-based and marine-based categories, while supportive regulatory frameworks and continuing product innovation are expected to sustain consumer demand for fortified products.
Key Players and Recent Developments
Competition in the North America omega 3 market is fueled by product innovation, quality, pricing, and distribution strategies. Major players include AKER BIOMARINE, BASF SE, Croda International Plc, GC Rieber, DSM-Firmenich AG, Omega Protein Corporation, Corbion, Nuseed Global, and Cargill Inc. Partnerships, mergers, and acquisitions are expected to drive consolidation and innovation. In March 2025, Natac launched Omega-3 Star, a premium fish oil–based solution designed for food, nutraceutical, and pet nutrition applications.
More Trending Latest Reports By Polaris Market Research:
viral-vector-bioanalytical-testing-services-market
feed-mycotoxin-detoxifiers-market
earth-observation-small-satellite-market